"Hypoxanthines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
| Descriptor ID |
D007042
|
| MeSH Number(s) |
D03.633.100.759.758.399
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypoxanthines".
Below are MeSH descriptors whose meaning is more specific than "Hypoxanthines".
This graph shows the total number of publications written about "Hypoxanthines" by people in this website by year, and whether "Hypoxanthines" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Hypoxanthines" by people in Profiles.
-
Synthetic and biological studies of tubulin targeting c2-substituted 7-deazahypoxanthines derived from marine alkaloid rigidins. ChemMedChem. 2014 Jul; 9(7):1428-1435.
-
Inosine reduces ischemic brain injury in rats. Stroke. 2005 Mar; 36(3):654-9.
-
Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells. Cancer Res. 1993 Dec 01; 53(23):5697-706.
-
Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. Biochem Pharmacol. 1993 Nov 02; 46(9):1627-36.
-
Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. Cancer Res. 1986 Dec; 46(12 Pt 1):6286-9.
-
Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. Cancer Res. 1982 Sep; 42(9):3884-6.
-
Human serum albumin phenotype activation in mouse hepatoma--human leukocyte cell hybrids. Science. 1974 Sep 06; 185(4154):859-62.